Geode Capital Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 773,235 shares of TARS stock, worth $25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

773,235

Previous 629,692 22.8%

Holding current value

$25 Million

Previous $22.9 Million 8.18%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.17 - $38.73 $3.61 Million - $5.56 Million	143,543 Added 22.8%	773,235 $21 Million
Q1 2024 May 13, 2024	BUY	$19.61 - $39.22 $391,337 - $782,674	19,956 Added 3.27%	629,692 $22.9 Million
Q4 2023 Feb 13, 2024	BUY	$12.98 - $20.73 $1.08 Million - $1.73 Million	83,476 Added 15.86%	609,736 $12.3 Million
Q3 2023 Nov 13, 2023	BUY	$14.75 - $24.62 $1.2 Million - $2 Million	81,399 Added 18.3%	526,260 $9.35 Million
Q2 2023 Aug 11, 2023	BUY	$11.57 - $19.63 $1.11 Million - $1.88 Million	95,712 Added 27.41%	444,861 $8.04 Million
Q1 2023 May 15, 2023	BUY	$11.92 - $16.27 $94,859 - $129,476	7,958 Added 2.33%	349,149 $4.39 Million
Q4 2022 Feb 13, 2023	BUY	$14.12 - $18.72 $165,345 - $219,211	11,710 Added 3.55%	341,191 $5 Million
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $892,629 - $1.17 Million	63,397 Added 23.83%	329,481 $5.64 Million
Q2 2022 Aug 12, 2022	BUY	$11.08 - $19.08 $1.5 Million - $2.58 Million	135,326 Added 103.49%	266,084 $3.88 Million
Q1 2022 May 13, 2022	BUY	$14.49 - $24.28 $71,624 - $120,016	4,943 Added 3.93%	130,758 $2.2 Million
Q4 2021 Feb 11, 2022	BUY	$21.21 - $29.68 $44,901 - $62,832	2,117 Added 1.71%	125,815 $2.83 Million
Q3 2021 Nov 12, 2021	SELL	$21.45 - $29.22 $39,103 - $53,268	-1,823 Reduced 1.45%	123,698 $2.67 Million
Q2 2021 Aug 13, 2021	BUY	$27.16 - $38.59 $644,017 - $915,046	23,712 Added 23.29%	125,521 $3.64 Million
Q1 2021 May 12, 2021	SELL	$27.37 - $47.25 $234,451 - $404,743	-8,566 Reduced 7.76%	101,809 $3.28 Million
Q4 2020 Feb 12, 2021	BUY	$19.17 - $49.62 $2.12 Million - $5.48 Million	110,375 New	110,375 $4.56 Million

Others Institutions Holding TARS

# of Institutions

155

Shares Held

40.4M

Call Options Held

37.9K

Put Options Held

808K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $860M
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History